Skip to content

INNOVATION PHARMACEUTICALS INC.: filings

Every INNOVATION PHARMACEUTICALS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filing record ends 2023-11-20

The latest filing in this captured record is a 10-Q filed 2023-11-20. No later filing is in the SEC companyfacts record captured on 2026-09-22. INNOVATION PHARMACEUTICALS INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-20fiscal Q1 202430630001477932-23-008688
10-K2023-09-28fiscal FY 202333660001477932-23-007158
10-Q2023-05-15fiscal Q3 202331880001477932-23-003414
10-Q2023-02-15fiscal Q2 202330780001477932-23-001071
10-Q2022-11-10fiscal Q1 202331650001477932-22-008313
10-K2022-09-28fiscal FY 202231660001477932-22-007292
10-Q2022-05-13fiscal Q3 202230810001477932-22-003285
10-Q2022-02-14fiscal Q2 202230820001477932-22-000779
10-Q2021-11-09fiscal Q1 202229600001477932-21-007937
10-K2021-09-27fiscal FY 202132620001477932-21-006717
10-Q2021-05-13fiscal Q3 202132930001477932-21-003093
10-Q2021-02-22fiscal Q2 202130800001477932-21-000999
10-Q2020-11-16fiscal Q1 202129600001477932-20-006561
10-K2020-09-14fiscal FY 202032640001477932-20-005387
10-Q2020-05-14fiscal Q3 202031810001477932-20-002637
10-Q2020-02-13fiscal Q2 202030740001477932-20-000605
10-Q2019-11-13fiscal Q1 202030610001477932-19-006354
10-K2019-09-30fiscal FY 201929580001477932-19-005611
10-Q2019-05-10fiscal Q3 201926780001477932-19-002567
10-Q2019-02-08fiscal Q2 201926680001477932-19-000383
10-Q2018-11-08fiscal Q1 201927520001477932-18-005343
10-K2018-09-11fiscal FY 201830600001477932-18-004457
10-Q2018-05-10fiscal Q3 201823660001477932-18-002302
10-Q2018-02-07fiscal Q2 201823640001477932-18-000676
10-Q2017-11-08fiscal Q1 201823460001477932-17-005408
10-K2017-09-11fiscal FY 201728960001477932-17-004400
10-Q2017-05-09fiscal Q3 201723660001477932-17-002123
10-Q2017-02-09fiscal Q2 201723660001477932-17-000651
10-Q2016-11-09fiscal Q1 201722440001477932-16-013308
10-K2016-09-13fiscal FY 2016281050001477932-16-012448
10-Q2016-05-09fiscal Q3 201623640001477932-16-010128
10-Q2016-02-08fiscal Q2 201623640001477932-16-008473
10-Q2015-11-09fiscal Q1 201626540001477932-15-006821
10-K2015-09-11fiscal FY 201526670001477932-15-005843
10-Q2015-05-11fiscal Q3 201523660001477932-15-002993
10-Q2015-02-09fiscal Q2 201524690001477932-15-001033
10-Q2014-11-10fiscal Q1 201523450001477932-14-005934
10-K2014-09-15fiscal FY 2014281000001477932-14-005027
10-Q/A2014-05-16fiscal Q3 201421860001477932-14-002681
10-Q2014-02-10fiscal Q2 201419810001477932-14-000589
10-Q2013-11-08fiscal Q1 201419620001548233-13-000024
10-K2013-09-30fiscal FY 201319580001171520-13-000616
10-Q2013-05-20fiscal Q3 201321780001548233-13-000008
10-Q2013-02-13fiscal Q2 201319730001548233-13-000005
10-Q2012-11-19fiscal Q1 201317520001548233-12-000021
10-K2012-10-12fiscal FY 201217550001548233-12-000017
10-Q2012-05-18fiscal Q3 201216550001144204-12-030606
10-Q2012-02-14fiscal Q2 201217600001144204-12-008656
10-Q2011-11-21fiscal Q1 201216470001144204-11-065926

Inspect the source

Entity
INNOVATION PHARMACEUTICALS INC. / CIK 0001355250
Captured
SEC response SHA-256
16f9a46a953f907c1d086cad016a5b045e6ee1cf4337a7d155b3765e6da56523

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001355250.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))